Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

T Rowe Price Health Sciences Fund Inc

+ Add to Watchlist

PRHSX:US

76.93 USD 0.58 0.75%

As of 09:29:30 ET on 04/01/2015.

Snapshot for T Rowe Price Health Sciences Fund Inc (PRHSX)

Year To Date: +14.00% 3-Month: +14.00% 3-Year: +36.53% 52-Week Range: 50.77 - 79.82
1-Month: +2.74% 1-Year: +41.92% 5-Year: +28.90% Beta vs SPX: 0.93

Mutual Fund Chart for PRHSX

No chart data available.
  • PRHSX:US 77.51
  • 1M
  • 1Y
Interactive PRHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PRHSX

T. Rowe Price Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine or the life sciences.

Inception Date: 12-29-1995 Telephone: 1-800-225-5132
Managers: TAYMOUR R TAMADDON
Web Site: www.troweprice.com

Fundamentals for PRHSX

NAV (on 2015-04-01) 76.93
Assets (M) (on 2015-02-27) 13,647.41
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PRHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-15) 1.00
Dividend Yield (ttm) 10.53

Fees & Expenses for PRHSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.64
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.79

Top Fund Holdings for PRHSX

Filing Date: 12/31/2014
Name Position Value % of Total
Allergan Inc/United States 2,545,600 541,169,104 4.598%
Gilead Sciences Inc 5,568,380 524,875,499 4.460%
Alexion Pharmaceuticals Inc 2,824,300 522,580,229 4.440%
Aetna Inc 4,186,583 371,894,168 3.160%
McKesson Corp 1,728,300 358,760,514 3.048%
UnitedHealth Group Inc 3,531,600 357,009,444 3.033%
Actavis plc 1,348,596 347,142,096 2.949%
Valeant Pharmaceuticals Intern 2,326,300 332,916,793 2.829%
Biogen Inc 842,000 285,816,900 2.428%
T Rowe Price Reserve Investmen 278,355,710 278,355,710 2.365%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil